Table 2:
Proportion Receiving Oral Anticoagulation by Index Device-Detected AF Episode Burden
| Index Device-Detected AF Episode Burden | ||||
|---|---|---|---|---|
| > 6 Minutes | > 1 Hour | > 6 Hours | > 24 Hours | |
| Included Patients | 2,101 | 1,712 | 1,279 | 818 |
| CHA2DS2-VASc Score (mean±SD) | 3.9 ± 1.4 | 4.0 ± 1.4 | 4.0 ± 1.4 | 4.2 ± 1.4 |
| HAS-BLED Score* (mean±SD) | 2.7 ± 1.1 | 2.6 ± 1.1 | 2.7 ± 1.1 | 2.8 ± 1.1 |
| OAC Prescribed†,‡ | 272 (13.0%) | 273 (16.0%) | 263 (20.6%) | 224 (27.4%) |
| Warfarin Prescribed | 258 (94.9%) | 257 (94.1%) | 246 (93.5%) | 208 (92.9%) |
| NOAC Prescribed | 14 (5.1%) | 17 (6.2%) | 18 (6.8%) | 18 (8.0%) |
| Days from Device-Detected AF to OAC (mean±SD) | 31.2 ± 24.6 | 31.9 ± 24.4 | 30.7 ± 24.0 | 33.3 ± 24.1 |
*
Excludes labile international normalized ratio component;
†
Within 90 days of index AF episode;
‡
Warfarin and NOAC prescription are not mutually exclusive within 90-days of index AF episode.
AF: atrial fibrillation; NOAC: non-vitamin K antagonist oral anticoagulants; OAC: oral anticoagulation; SD: standard deviation